Long-acting antiretroviral therapy

dc.contributor.author	Soriano, Vicente
dc.contributor.author	Barreiro, Pablo
dc.contributor.author	Mendoza, Carmen de
dc.date	2020-08-01
dc.date.accessioned	2020-10-06T15:03:17Z
dc.date.available	2020-10-06T15:03:17Z
dc.description.abstract	Nanoformulations of cabotegravir prodrugs have been developed to prolong the pharmacokinetics of the antiretroviral agent. They can be present in the plasma of mice and non-human primates for a year following a single injection.	es_ES
dc.identifier.doi	https://doi.org/10.1038/s41563-020-0731-7
dc.identifier.issn	14761122
dc.identifier.uri	https://reunir.unir.net/handle/123456789/10640
dc.language.iso	eng	es_ES
dc.publisher	Nature Materials	es_ES
dc.relation.ispartofseries	;vol. 19, nº 8
dc.relation.uri	https://www.nature.com/articles/s41563-020-0731-7	es_ES
dc.rights	openAccess	es_ES
dc.subject	Scopus	es_ES
dc.subject	JCR	es_ES
dc.title	Long-acting antiretroviral therapy	es_ES
dc.type	Articulo Revista Indexada	es_ES
opencost.publication.doi	https://doi.org/10.1038/s41563-020-0731-7
reunir.tag	~ARI	es_ES

Archivos

Mostrando 1 - 1 de 1